The neuronal microtubule-associated protein, tau, is expressed as a set of isoforms containing either three or four tandemly repeated 31-amino-acid motifs in the C-terminal half of the molecule that can bind to microtubules. Threerepeat forms are the only ones expressed early in development. A single three-repeat isoform of tau has been stably expressed in non-neuronal cells which do not express endogenous tau. Chinese hamster ovary (CHO) cells were transfected with a full-length cDNA coding for the foetal form of human tau cloned downstream of the simian virus 40 (SV40) promoter, and a cell line constitutively expressing tau, CHO[pSVtau3], was isolated. Double-label immunofluorescence microscopy reveals that tau co-localizes with the microtubular network of normal or taxol-treated CHO[pSVtau3] cells, without inducing any dramatic change in cell morphology. Tau is expressed in CHO[pSVtau3] cells as three bands in SDS/PAGE recognized by antibodies to tau, the slow-migrating tau species being the most abundant. Tau also appears as three bands in a heat-stable fraction from CHO[pSVtau3] cells, but a single band of enhanced immunoreactivity is detected following treatment of this fraction with alkaline phosphatase. This single band co-migrates with the fastmigrating band of untreated fractions or whole-cell extracts. In conclusion, a three-repeat isoform of tau is capable of binding to microtubules in transfected non-neuronal cells; furthermore, in this system, the protein is phosphorylated in at least two different states inducing a reduced electrophoretic mobility.
INTRODUCTION
Neuronal polarity is highly correlated with the properties of microtubules present in axons and dendrites. For instance, microtubules are uniformly oriented in axons, e.g. their plus ends are directed distal to the cell body, whereas microtubules with mixed orientations are found in dendrites (Baas et al., 1988 (Baas et al., , 1989 . Microtubules in axons and dendrites also differ in their microtubule-associated proteins (MAPs): the high-molecularmass MAP2 is found in dendrites and cell bodies (Matus et al., 1981; DeCamilli et al., 1984) , whereas tau proteins are specifically axonal (Binder et al., 1985; Dotti et al., 1987; Brion et al., 1988) .
MAPs appear to have a role in neurite outgrowth, since experiments using antisense techniques have shown that MAP2 was responsible for neurite extension in embryonal carcinoma cells (Dinsmore & Solomon, 1991) and that tau was necessary for both differentiation and maintenance of axonal processes in cerebellar neurones in primary culture (Caceres & Kosik, 1990; Caceres et al., 1991) . These latter data, together with the earlier observation that tau and MAP2 do not segregate before a neurite has developed an axonal morphology (Kosik & Finch, 1987) , suggest that tau functions after an initial period of growth. The role of tau in process growth is further emphasized by the extension of long processes induced by overexpression of tau in Sf9 insect cells infected with a recombinant baculovirus containing a tau cDNA insert (Knops et al., 1991) .
Tau proteins are a group of at least six isoforms generated by alternative RNA splicing (Goedert et al., 1989a,b; Himmler et al., 1989; Kosik et al., 1989) . Tau isoforms contain either three or four tandemly repeated similar 31-amino-acid sequences in its C-terminal half which are microtubule-binding sites (Aizawa et al., 1989; Ennulat et al., 1989; Himmler et al., 1989; Lee et al., 1989) . The expression of tau isoforms is regulated during development (Francon et al., 1982) . Three-repeat isoform(s) are the only one(s) expressed until day 20 of embryonic growth in rat , and are the only forms present in human foetal brain (Goedert et al., 1989a,b) ; thus they are likely to play a role in axonal elongation during development.
Tau is phosphorylated in brain and phosphorylation appears to regulate the binding oftau to microtubules, since dephosphorylation of tau increases its ability to promote microtubule assembly in vitro (Lindwall & Cole, 1984) . Furthermore, a phosphorylated form of tau found in brains of people with Alzheimer's disease, referred to as A68, is not capable of binding to microtubules . Individual bacterially expressed tau isoforms can be phosphorylated in vitro by purified kinases, including Ca2+/calmodulin-dependent protein kinase and protein kinase C (Steiner et al., 1990) . However, an issue that remains unresolved by such studies is the pattern of phosphorylation of individual tau isoforms in a cellular environment. This can be directly assessed in non-neuronal cells, which do not express endogenous tau, transfected with cDNAs coding for single tau isoforms. Such an approach has been used by Kanai et al. (1989) § To whom correspondence should be addressed.
EXPERIMENTAL
Construction of pSVtau3 expression plasmid The isolation of clone p19, which contains a cDNA insert coding for the entire human foetal tau, has been described previously . The vector was obtained from the plasmid pSV2neo (Southern & Berg, 1982) by removing the aminoglycoside phosphotransferase (neor) gene. The plasmids p19 and pSV2neo were digested with SalI and HindIII, respectively, and blunt-ended with the Klenow fragment of Escherichia coli DNA polymerase I. The DNA fragments were then digested with EcoRI and the digestion products were separated by electrophoresis in 1 % (w/v) low-melting-point agarose. The tau cDNA insert and the linearized vector were excised from the gel and purified by phenol and chloroform extractions (Sambrook et al., 1989) . The tau cDNA fragment and the vector were ligated at the EcoRI site with T4 DNA ligase and the resulting DNA was circularized by overnight incubation at 14°C with T4 DNA ligase. The reaction mixture was used to transform competewtE. coli HBOlE cells. These manipulations were carried out according to standard protocols (Ausubel et al., 1990) . A clone containing the tau insert ligated to the vector was selected by restriction digestion analysis. Large-scale plasmid DNA purification was carried out on Qiagen pack 500 columns (Diagen G.m.b.H, Dusseldorf, Germany) according to the manufacturer's instructions.
Cell culture and transfection CHO cells were maintained in a-minimal essential medium supplemented with 10% (v/v) foetal calf serum (Gibco/BRL, Paisley, Scotland, U.K.). A total of 106 cells were plated in 25 cm2 flasks and co-transfected the following day with 7,ug of pSVtau3 and 0.35 ,ug of pSV2neo by the calcium phosphate method (Graham & van der Eb, 1973) . Cells were incubated for 6 h with the DNA/calcium phosphate precipitate and subsequently subjected to a 3 min glycerol shock. Transfected cells were selected by growing them in the presence of 500,ug of G-418/ml (Geneticin; Gibco/BRL) for 2 weeks. Cells were cloned by limiting dilution, and screening for tau-expressing cells was performed by indirect immunofluorescence with a polyclonal antibody to tau (see below). In some experiments, cells were treated overnight with 10 ,umol of taxol/l (provided by the National Cancer Institute, Bethesda, MD, U.S.A.).
Antibodies
The mouse monoclonal anti-tau antibody, tau 1 (Binder et al., 1985) , was generously provided by Dr. Lester Binder (University of Birmingham, Birmingham, AL, U.S.A.), and the mouse monoclonal anti-tau antibody 5E2 was described previously (Kowal & Kosik, 1987) . A mouse monoclonal antibody to f8-tubulin was purchased from Amersham (Amersham, Bucks., U.K.). A polyclonal antibody to human tau was also prepared by immunizing a rabbit with a tau-enriched fraction prepared from post-mortem human brain by the perchloric acid (PCA) method (PCA tau) as described elsewhere (Baudier & Cole, 1987; Greenberg & Davies, 1990; Hanger et al., 1991) . For affinity purification, tau was further purified from PCA tau by phosphocellulose chromatography (Weingarten et al., 1975) and coupled to an Aminolink column (Pierce, Oud-Beijerland, The Netherlands). This column was used to affinity purify antibodies to tau from the rabbit antiserum, according to the manufacturer's instructions.
Immunofluorescence microscopy
For immunofluorescence staining, cells grown on untreated glass coverslips were washed in Tris-buffered saline and fixed for 5 min in acetone at -20 'C. Primary antibodies were affinitypurified polyclonal anti-tau antibody (9 jig/ml) alone or mixed with anti-fl-tubulin monoclonal antibody (diluted 1:100).
Fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG and tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse IgG (Nordic, Maidenhead, Berks., U.K.), diluted 1: 35, were used as secondary antibodies.
Biochemical procedures
Control and transfected cells were harvested and homogenized in electrophoresis sample buffer [62.5 mmol/1 Tris HCI, 2% (w/v) SDS, 5 % (v/v) 2-mercaptoethanol, 10% (v/v) glycerol and 0.005 % (w/v) Bromophenol Blue, pH 6.8]. Proteins were resolved by SDS/PAGE in 10 % (w/v) polyacrylamide gels according to Laemmli (1970) , and blotted on to nitrocellulose by the method of Towbin et al. (1979) . Nitrocellulose sheets were incubated with anti-tau antibodies and antibody binding was detected-by appropriate secondary biotinylated antibodies followed by either alkaline phosphatase-or peroxidase-conjugated streptavidin (Amersham). The monoclonal antibodies tau 1 and 5E2 were used as culture supernatants diluted 1:300 and 1:7.5 respectively; the affinity-purified polyclonal anti-tau antibody was used at 1 ,ug/ml. A heat-stable fraction from CHO[pSVtau3] cells was prepared by homogenizing cells from four subconfluent 80 cm2 flasks into 240 ,l of Mes/NaCl buffer [Mes 100 mmol/1, MgCl2 0.5 mmol/l, EGTA 2 mmol/l, NaCl 1 mol/l, dithiothreitol 2 mmol/1 (pH 6.5)] and heated at 100 'C for S min.
The suspension was centrifuged at 16 000 g8v for 15 min and the supernatant was recovered. The heat-stable fraction of CHO[pSVtau3] cells was dephosphorylated for 28 h at 37 'C with 30 units of E. coli alkaline phosphatase/ml by using the method described by Kanai et al. (1989) . The enzyme was omitted from controls. The incubation mixture was then prepared for SDS/PAGE by adding 0.25 vol. of five times concentrated electrophoresis sample buffer.
RESULTS

Expression plasmid
The plasmid p19, isolated from Agtl 1 human foetal brain expression library , was used for the purpose of expressing tau in CHO cells. p19 contains a 2.5 kb cDNA insert coding for the full-length sequence of a three-repeat isoform of tau, without an N-terminal insert, plus a 1.2 kb 3' flanking sequence. Sall cleaves this cDNA insert at an unique site, 28 bases upstream from the ATG translation initiation codon. The Sail/EcoRI fragnent of the cDNA insert has been subcloned downstream to the simian virus 40 (SV40) early promoter; the resulting 4.95 kb plasmid vector has been designated pSVtau3. with the well-characterized monoclonal antibodies, tau 1 and 5E2, to defined epitopes of tau (Figs. la and lb), and with an affinity-purified polyclonal antibody to human tau (Fig. ic) . In each case, tau was expressed as a set of three immunoreactive bands. The slow-migrating species appears to be the most abundant, irrespective of the antibody used for detection. The high-mobility tau species of CHOfpSVtau3] cells co-migrates with the fast-migrating tau band ofhuman brain (Fig. ld, double  arrow) . This band represents the 352-amino-acid-long tau isoform that has been determined to have a true molecular mass of 36760 Da and an apparent molecular mass of48000 Da (Goedert & Jakes, 1990) .
Subcelillar distribution of tau in CHO[pSVtau3l cells
An affinity-purified polyclonal antibody to human tau stained a filamentous network in the cytoplasm of CHO[pSVtau3] cells that radiated from the juxtanuclear region (Fig. 2a) . In some cells, the centrioles can be clearly distinguished (Fig. 2b) . Some mitotic spindles were also observed with the antibody (not shown).
Double immunofluorescence staining showed that the staining pattern obtained with antibodies to tau was indistinguishable from that with a monoclonal antibody to fl-tubulin (Figs. 3a, and 3c) . No bundles of microtubules similar to those described by Kanai et al. (1989) and Lewis et al. (1989) were observed. To confirm further the co-localization of tau and microtubules in CHO[pSVtau3] cells, the cells were treated with the microtubulestabilizing drug taxol. Exposure of cultured cells to taxol induces the formation of microtubule bundles (Schiff & Horwitz, 1980) .
After an overnight incubation with 10 /umol of taxol/1, CHO[pSVtau3] cells were processed for double immunofluorescence staining. The taxol-induced microtubule bundles were clearly identified by the anti-fl-tubulin antibody, and were also stained by anti-tau antibodies (Figs. 3b and 3d (Fig. 4a) , stained by both tau 1 (Fig. 4a ) and the polyclonal antibody to tau (Fig. 4b) . The heat-stable fraction from CHO[pSVtau3] cells was treated for 28 h with 30 units of E. coli alkaline phosphatase/ml. This treatment resulted in the disappearance of the two slow-migrating bands and in an enhanced immunoreactivity of the fast-migrating band for both the monoclonal antibody tau 1 (Fig. 4c ) and the polyclonal antibody to tau (results not shown). Lower loadings of the alkaline phosphatase-treated sample on a gel show that dephosphorylated tau co-migrates with the fast-migrating tau band of the untreated fraction (Fig. 4c, lane 3 (Lewis et al., 1989) . The only such cell line, other than CHO[pSVtau3] , that has been reported expresses an adult form of rat tau (Kanai et al., 1989) .
Tau isoforms contain either three or four tandem repeats of 31-amino-acid sequences in the C-terminal half of the molecule (Goedert et al., 1988 (Goedert et al., , 1989a Lee et al., 1988; Kosik et al., 1989) that are tubulin-binding sites (Aizawa et al., 1989; Ennulat et al., 1989; Himmler et al., 1989; Lee et al., 1989) . In vitro, both threeand four-repeat isoforms of tau promote tubulin polymerization, but the rate of polymerization is up to three times faster with four-repeat forms than with three-repeat forms (Goedert & Jakes, 1990 (Drubin & Kirschner, 1986) and transfection of various cell types with three-repeat (Lewis et al., 1989) and four-repeat (Kanai et al., 1989) forms of tau.
In the latter systems, the expression of tau resulted in the formation of bundles of parallel arrays of microtubules. MAP2, which possesses three tubulin-binding domains homologous to their tau counterparts (Lewis et al., 1988) , also induces microtubule bundling in transfected cells (Lewis et al., 1989) . Microtubule bundling was essentially observed in transiently transfected cells, but a few microtubule bundles were present in a mouse L cell line stably transfected with a four-repeat isoform of rat tau (Kanai et al., 1989) In vitro, phosphorylation of tau by Ca2+/calmodulin-dependent kinase induces an electrophoretic shift, on both previously dephosphorylated brain tau (Baudier & Cole, 1987) and bacterially synthesized recombinant tau (Steiner et al., 1990) . Such a shift has also been found with cyclic AMP-dependent protein kinase (Litersky & Johnson, 1992 ; J. Robertson, T. Loviny, M. Goedert, R. Jakes, K. Murray, B. Anderton & D. Hanger, unpublished work) . A site phosphorylated in vitro by Ca2+/ calmodulin-dependent kinase has been identified as Ser-405 in a 430-amino-acid sequence of bovine tau, and phosphorylation at this site is sufficient to induce a shift in tau mobility (Steiner et al., 1990 ). An explanation for the reduced electrophoretic mobility of some phosphorylated forms of tau is provided by electron microscopy observations showing a major change in tau structure, such that it becomes long and stiff after phosphorylation by Ca2+/calmodulin-dependent kinase (Hagestedt et al., 1989 ).
Here we show that a single three-repeat isoform of human tau can be phosphorylated in vivo in at least two different states of this type. The two observed bands might reflect a different extent of phosphorylation by the same kinase, possibly Ca2+/calmodulin-dependent kinase, or the presence in CHO cells of at least two kinases inducing an electrophoretic shift of tau. Elucidating the regulatory mechanisms of this type of tau phosphorylation is important because of its occurrence in hyperphosphorylated tau in Alzheimer's disease (Flament & Delacourte, 1989; Hanger et al., 1991; Lee et al., 1991) .
In conclusion, we have shown that a three-repeat isoform of human tau bound to microtubules and was phosphorylated in a stably transfected non-neuronal cell line. Furthermore, the properties of tau in CHO[pSVtau3] cells appear to differ from those previously reported in another system (Kanai et al., 1989) , and this suggests the occurrence of isoform-specific properties of tau, including phosphorylation and association with the microtubule network. 
